Pāriet uz galveno navigāciju Pāriet uz meklēšanu Pāriet uz galveno saturu

Predictors of sputum culture conversion among patients treated for multidrug-resistant tuberculosis

  • Ekaterina Kurbatova*
  • , V. M. Gammino
  • , J. Bayona
  • , M. C. Becerra
  • , M. Danilovitz
  • , D. Falzon
  • , I. Gelmanova
  • , S. Keshavjee
  • , V. Leimane
  • , C. D. Mitnick
  • , M. I. Quelapio
  • , V. Riekstina
  • , A. Taylor
  • , P. Viiklepp
  • , M. Zignol
  • , J. P. Cegielski
  • *Šī darba korespondējošais autors
  • Centers for Disease Control and Prevention
  • Partners in Health
  • Harvard University
  • Eye Clinic of Tartu University Hospital
  • World Health Organization
  • Infectology Center of Latvia
  • Tropical Disease Foundation
  • National Institute for Health Development

Zinātniskās darbības rezultāts: Devums žurnālam › Zinātniskais raksts (žurnālā) › koleģiāli recenzēts

73 Atsauces (Scopus)

Kopsavilkums

OBJECTIVE: To identify predictors of initial sputum culture conversion, estimate the usefulness of persistent positive cultures at different time points in predicting treatment failure, and evaluate different definitions of culture conversion for predicting failure among patients with multidrug-resistant tuberculosis (MDR-TB) in five countries, 2000-2004. METHODS: Predictors of time to conversion were identified using multivariate Cox proportional hazards regression modeling. Receiver operating characteristic curves were plotted to visualize the effect of using different definitions of 'culture conversion' on the balance between sensitivity and specificity. RESULTS: Overall, 1209/1416 (85%) of patients with baseline positive cultures converted in a median of 3.0 months (interquartile range 2.0-5.0). Independent predictors of less likely conversion included baseline positive smear (hazard ratio [HR] 0.60, 95%CI 0.53-0.68), resistance to pyrazinamide (HR 0.82, 95%CI 0.70-0.96), fluoroquinolones (FQs; HR 0.65, 95%CI 0.51-0.83) or thioamide (HR 0.83, 95%CI 0.71-0.96), previous use of FQs (HR 0.71, 95%CI 0.60-0.83), poor outcome of previous anti-tuberculosis treatment (HR 0.69, 95%CI 0.54-0.88) and alcoholism (HR 0.74, 95%CI 0.63-0.87). The maximum combined sensitivity (84%) and specificity (94%) in predicting treatment failure was based on lack of culture conversion at month 9 of treatment, assuming conversion is defined as five consecutive negative cultures. CONCLUSION: Patients with identified risk factors were less likely to achieve sputum culture conversion during MDR-TB treatment.

OriģinālvalodaAngļu
Lapas (no-līdz)1335-1343
Lapu skaits9
ŽurnālsInternational Journal of Tuberculosis and Lung Disease
Sējums16
Izdevuma numurs10
DOIs
Publikācijas statussPublicēts - okt. 2012
Ārēji publicētsJā

ANO IAM

Šis izpildes rezultāts palīdz sasniegt šādus ANO ilgtspējīgas attīstības mērķus (IAM)

  1. 3. IAM — Laba Veselība un Labbūtība
    3. IAM — Laba Veselība un Labbūtība

Nospiedums

Uzziniet vairāk par pētniecības tēmām “Predictors of sputum culture conversion among patients treated for multidrug-resistant tuberculosis”. Kopā tie veido unikālu nospiedumu.

Citēt šo